Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development.
Ting SongNa HeZiqian HaoYunfan YangPublished in: Journal of cellular physiology (2023)
Diffuse large B cell lymphoma (DLBCL) is a common and aggressive form of B cell lymphoma. Approximately 40% of DLBCL patients are incurable despite modern therapeutic approaches. To explore the molecular mechanisms driving the growth and progression of DLBCL, we analyzed genes with differential expression in DLBCL using the Gene Expression Profiling Interactive Analysis database. Enkurin domain-containing protein 1 (ENKD1), a centrosomal protein-encoding gene, was found to be highly expressed in DLBCL samples compared with normal samples. The phylogenetic analysis revealed that ENKD1 is evolutionarily conserved. Depletion of ENKD1 in cultured DLBCL cells induced apoptosis, suppressed cell proliferation, and blocked cell cycle progression in the G2/M phase. Moreover, ENKD1 expression positively correlates with the expression levels of a number of cellular homeostatic regulators, including Sperm-associated antigen 5, a gene encoding an important mitotic regulator. These findings thus demonstrate a critical function for ENKD1 in regulating the cellular homeostasis and suggest a potential value of targeting ENKD1 for the treatment of DLBCL. This article is protected by copyright. All rights reserved.
Keyphrases
- diffuse large b cell lymphoma
- cell cycle
- induced apoptosis
- cell proliferation
- epstein barr virus
- genome wide
- genome wide identification
- poor prognosis
- endoplasmic reticulum stress
- signaling pathway
- transcription factor
- copy number
- oxidative stress
- end stage renal disease
- binding protein
- chronic kidney disease
- dna methylation
- ejection fraction
- long non coding rna
- endothelial cells
- pi k akt
- climate change
- protein protein
- small molecule
- single cell
- human health
- bioinformatics analysis